May 5, 2020 / 10:23 AM / a month ago

BRIEF-Athersys Announces Commencement Of Patient Enrollment In The Macovia Study

May 5 (Reuters) - Athersys Inc:

* ATHERSYS ANNOUNCES COMMENCEMENT OF PATIENT ENROLLMENT IN THE MACOVIA STUDY, A PIVOTAL PHASE 2/3 TRIAL EVALUATING MULTISTEM® CELL THERAPY FOR COVID-19 INDUCED ARDS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below